Home › Crohn's Disease › District of Columbia
Crohn's Disease clinical trials in District of Columbia
4 studies for Crohn's Disease are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT03816345A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Emerson Clinical Research Institute ( Site 5051), Washington D.C.
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 2, 2026 · NCT06430801Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- MedStar Georgetown University Hospital, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173Therapeutic Endpoint in Pediatric IBD Conditions
- Children's National Health System, Washington D.C.
RecruitingObservational study
Ages 6 to 21 · All sexes · Updated Apr 8, 2026 · NCT06065228From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.